Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CYCN
CYCLERION THERAPEUTICS, INC.
NASDAQ
$3.79
▼ DOWN 5.01% (-0.20)

KEY STATISTICS

Market Cap$17.74 M
52w High$8.48
52w Low$1.03
Dividend Yield—
Frequency—
P/E-3.30
Volume60.01K
Shares Out.4.68M

COMPANY

LEADERSHIP

Regina Graul
CHIEF EXECUTIVE
Regina Graul

COMPENSATION 2026

Salary$390,831
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$35,327
Total$874,823

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 18, 2019
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
1

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.$900.00K
NOV
11
WED

SPLIT RECORD

DATETYPERATIO
2026-09-09Reverse1:7
2023-05-16Reverse1:20

PRICE

$3.79 ▼ DOWN 5.01% (−$0.20)
OVERLAYS
$3.80$3.90$4.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM3.79

About Cyclerion Therapeutics, Inc.

https://www.cyclerion.com ↗

Cyclerion Therapeutics, a Cambridge-based biotech, develops CNS-focused medicines like CY6463 and Praliciguat, targeting diseases such as Alzheimer's, mitochondrial disorders, hypertension, and sickle cell disease.

INDUSTRY

Biotechnology

A PRODUCT CYCLERION THERAPEUTICS, INC. IS KNOWN FOR

CYC-126
CYC-126

CYC-126 is an investigational, personalized therapy for treatment-resistant depression that uses anesthetic agents, real-time EEG feedback, and algorithm-guided dosing to target brain states linked to antidepressant effects.

COMPETITORS

COMPETITOR
AXSM COMPARE
CMPS COMPARE
RLMD COMPARE

Revenue by Products

IconPRODUCTFY2024
License Agreement$1.75M
License$250K

ETFS HOLDING THIS STOCK

ETFS HOLDING
5
LISTED HERE
3
RANKED BY POSITION SIZE
VXF
0.00% · 30.9K
ONEQ
0.00% · 21.3K
DFSU
0.00% · 3.3K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
20.37%
HOLDERS
35
TOP 12 OF 35 · RANKED BY POSITION SIZE
Trustcore Financial Services, LLC
292.6K sh · $192.03K
Tyndall Capital Partners L P
155.2K sh · $451.59M
Siren, L.L.C.
116.2K sh · $267.16K
Qs Investors, LLC
116.0K sh · $453K
Geode Capital Management, LLC
84.5K sh · $129.8K
Drw Securities, LLC
43.6K sh · $100.32K
Two Sigma Investments, LP
41.6K sh · $52.77K
Two Sigma Advisers, LP
28.3K sh · $35.94K
Vanguard Group Inc
23.5K sh · $29.83K
Citadel Advisors LLC
18.3K sh · $28.03K
Blackrock Inc.
17.2K sh · $39.49K
Blackrock, Inc.
16.8K sh · $26.04K

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book2
Overall Score1

INSIDER TRADES

★
DIRECTOR, OFFICER: SEE REMARKS
Graul Regina Margaret
Sale · 48.6K shares
2026-08-14
★
OFFICER: CHIEF FINANCIAL OFFICER
CHICKO RHONDA M.
Purchase · 25.0K shares
2026-08-14
★
OFFICER: CHIEF FINANCIAL OFFICER
CHICKO RHONDA M.
Sale · 25.0K shares
2026-08-14
★
DIRECTOR, OFFICER: SEE REMARKS
Graul Regina Margaret
Purchase · 55.8K shares
2026-08-14

SECTORS PEERS

PEERPRICE
XTLB$2.47COMPARE
KTTA$0.56COMPARE
PLRZ$13.14COMPARE
QNRX$6.12COMPARE
ADXN$3.84COMPARE
TCRT$1.60COMPARE
RADX$2.41COMPARE